Osteoarthritis Trial, Recruiting NCT06075004 Sponsor: University of Chile Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06075004
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been rated by an anesthesiologist as being in generally good to moderate health before surgery (this is called ASA classification 1–3; confirm with trial site if unsure which category applies to you)
  • Your body mass index (BMI) — a measure based on your height and weight — is between 20 and 35

Who may not be able to join:

  • Adults who are not able to give their own consent to participate
  • You have a pre-existing nerve condition or nerve damage (such as numbness, tingling, or weakness) identified by your doctor
  • You have a blood clotting problem, identified through your medical history, physical exam, or blood tests
  • You have kidney failure or significantly reduced kidney function, identified through your medical history, physical exam, or blood tests
  • You have liver failure or significantly reduced liver function, identified through your medical history, physical exam, or blood tests
  • You have a known allergy to local anesthetics (numbing medications) or morphine (a painkiller)
  • You are pregnant
  • You have had a previous surgery in the groin area on the same side as the planned surgery
  • You currently live with a long-term pain condition that requires you to regularly take opioid pain medications (such as morphine or codeine) at home

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniela Bravo, MD, University of Chile

Phone: 569222878209

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Chile
Registry
ClinicalTrials.gov
Start date
18 October 2023
Est. completion
15 October 2025

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Presence of quadriceps motor block (defined as paralysis or paresis)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov